BrainsWay Receives FDA Clearance for Ending Smoking Addiction in Adults
BrainsWay Ltd. (NASDAQ & TASE: BWAY), a global leader in the advanced non-invasive treatment of brain disorders, has received 510(k) clearance from the U.S. Food
Concenter BioPharma Successfully Uses Crowdfunding to Finance Its Pill To End Diabetes!
Concenter BioPharma has raised $407 K (as of August 24 1.3 Million NIS) in just ten days using the PipelBiZ Crowdfunding Platform! Concenter Biopharma launched
Nanox raises $165.2m in Nasdaq IPO!
Congratulations to Ran Poliakine! The largest-ever IPO of an early stage Israeli medical technology company was completed at a company valuation of $800 million! Israeli
Alternative Meat Company SavorEat Raises $4.75 M
SavorEat announced that it raised Funds from The Mor and Meitav Dash investment houses will invest $3 million, and $1.75 million was raised from the
Kamada’s COVID Antibody Drug Small Trial, a World 1st, gets Flying Start at Hadassah in Jerusalem
The world’s first clinical trial for a coronavirus drug made from antibodies got off to a promising start at the Hadassah hospital in Jerusalem, with
Will Nanox be the Next Israeli Hit on Nasdaq?
NANO-X IMAGING LTD , an innovative medical imaging technology company, has secured over $110M in crossover equity investments from global investors since December 2019. Funds
EDAS Instant Respiratory Diagnosis wins Israel Innovation Authority COVID-19 Grant
EDAS Healthcare is a patented decision support software, enabling immediate prediction of an infectious disease, upon the first patient encounter with a physician. Based on
Future Meat wins Calcalist’s FoodTech innovation startup contest
Future Meat Technologies Ltd. was crowned Wednesday as the winner of Calcalist’s startup contest, in partnership with Tnuva, aimed at finding the next great FoodTech
FDA OKs KAHR Medical IND Application for DSP107, anti-CD47 Candidate for Solid Tumors Treatment
KAHR Medical, a cancer immunotherapy company developing novel bi-functional fusion proteins, announced today that the U.S. Food and Drug Administration has cleared its investigational new
